Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05925491
Title Pembrolizumab in Locally Advanced Sinonasal Carcinoma (NeoPeSino)
Acronym NeoPeSino
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istituti Clinici Scientifici Maugeri SpA
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
Istituti Clinici Scientifici Maugeri Pavia Lombardia 27100 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field